Northern Trust Corp Reduces Holdings in Anthem Inc (NYSE:ANTM)

Share on StockTwits

Northern Trust Corp decreased its stake in Anthem Inc (NYSE:ANTM) by 4.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,023,635 shares of the company’s stock after selling 126,529 shares during the period. Northern Trust Corp owned 1.16% of Anthem worth $719,716,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC raised its position in Anthem by 4.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 4,672 shares of the company’s stock worth $1,162,000 after buying an additional 203 shares during the last quarter. Steward Partners Investment Advisory LLC grew its stake in shares of Anthem by 47.3% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 638 shares of the company’s stock worth $152,000 after purchasing an additional 205 shares during the period. Ballentine Partners LLC grew its stake in shares of Anthem by 14.6% during the 2nd quarter. Ballentine Partners LLC now owns 1,647 shares of the company’s stock worth $393,000 after purchasing an additional 210 shares during the period. Wilbanks Smith & Thomas Asset Management LLC grew its stake in shares of Anthem by 2.6% during the 2nd quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 8,387 shares of the company’s stock worth $1,996,000 after purchasing an additional 216 shares during the period. Finally, First Citizens Bank & Trust Co. grew its stake in shares of Anthem by 1.1% during the 2nd quarter. First Citizens Bank & Trust Co. now owns 20,285 shares of the company’s stock worth $4,828,000 after purchasing an additional 228 shares during the period. Institutional investors and hedge funds own 86.70% of the company’s stock.

In other Anthem news, CAO Ronald W. Penczek sold 763 shares of Anthem stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $265.56, for a total value of $202,622.28. Following the completion of the transaction, the chief accounting officer now owns 1,334 shares of the company’s stock, valued at $354,257.04. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Craig E. Samitt sold 19,541 shares of Anthem stock in a transaction on Thursday, July 26th. The stock was sold at an average price of $246.68, for a total transaction of $4,820,373.88. Following the completion of the transaction, the executive vice president now directly owns 20,857 shares of the company’s stock, valued at approximately $5,145,004.76. The disclosure for this sale can be found here. Insiders have sold 31,488 shares of company stock valued at $8,027,655 in the last three months. Corporate insiders own 0.31% of the company’s stock.

ANTM has been the topic of a number of recent analyst reports. Zacks Investment Research cut shares of Anthem from a “buy” rating to a “hold” rating in a research note on Tuesday, June 19th. ValuEngine raised shares of Anthem from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. BMO Capital Markets raised shares of Anthem from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $275.00 to $290.00 in a research note on Monday, July 9th. Cantor Fitzgerald reissued a “buy” rating and issued a $275.00 price objective on shares of Anthem in a research note on Wednesday, July 25th. Finally, Morgan Stanley increased their price objective on shares of Anthem from $269.00 to $273.00 and gave the company an “equal weight” rating in a research note on Thursday, July 26th. Three analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $274.21.

Shares of ANTM traded up $2.89 during mid-day trading on Friday, reaching $271.41. 1,325,569 shares of the stock traded hands, compared to its average volume of 1,370,646. Anthem Inc has a 12-month low of $182.31 and a 12-month high of $280.43. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $71.24 billion, a P/E ratio of 22.54, a P/E/G ratio of 1.49 and a beta of 0.92.

Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, July 25th. The company reported $4.25 earnings per share for the quarter, topping analysts’ consensus estimates of $4.16 by $0.09. Anthem had a net margin of 4.79% and a return on equity of 13.28%. The business had revenue of $22.71 billion during the quarter, compared to the consensus estimate of $22.66 billion. During the same quarter last year, the company earned $3.37 earnings per share. The business’s quarterly revenue was up 2.3% compared to the same quarter last year. Equities analysts expect that Anthem Inc will post 15.48 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 25th. Stockholders of record on Monday, September 10th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date was Friday, September 7th. Anthem’s payout ratio is currently 24.92%.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Further Reading: Return on Investment (ROI) Defined, Explained

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.